Delivery Order SPE2DB22D3501-SPE2DB24FWL99

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-inject devices to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,248.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price and an ultimate completion date of July 2, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The $1,012.42 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on August 16, 2024, with a completion date of August 19, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The $11,803.92 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a defense agency. The $1,392.30 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 14, 2025 with a completion date of May 15, 2025. The contract is a delivery order placed under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds...
The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The $2,081.46 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that provides medical products to federal government agencies, particularly military and veterans' healthcare programs. The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical products to the Defense Logistics Agency (DLA). The $5,218.24 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 20, 2025, with a completion date of March 21, 2025. The contract is a delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of 4,566,077,688 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm fixed price delivery order. The contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and has been awarded this $3,301.26 contract with a completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $1,786.95 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of 4,565,536,694 units of epinephrine 0.3 mg auto-injectors. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical...
The federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $11,099.01, was awarded to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is a Firm Fixed Price delivery order with a completion date of September 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,943.21, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a performance period ending on June 26, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWL99
    Delivery Order

The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,075.32 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that has been awarded numerous contracts by the DLA and other federal agencies. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by August 1, 2024.

Generated 10/30/24, 9:27 AM